Syra Health Corp.
SYRA
$0.07
-$0.01-11.19%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.69M | 1.95M | 1.86M | 2.01M | 2.25M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.69M | 1.95M | 1.86M | 2.01M | 2.25M |
| Cost of Revenue | 1.13M | 1.19M | 1.27M | 1.55M | 1.59M |
| Gross Profit | 554.50K | 752.90K | 589.20K | 455.40K | 668.30K |
| SG&A Expenses | 780.50K | 780.40K | 1.02M | 954.90K | 1.04M |
| Depreciation & Amortization | 5.40K | 6.00K | 6.80K | 7.30K | 25.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.92M | 2.01M | 2.33M | 2.51M | 2.68M |
| Operating Income | -232.20K | -63.20K | -473.30K | -501.70K | -428.90K |
| Income Before Tax | -225.90K | -63.60K | -472.30K | -504.40K | -417.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -225.90K | -63.60K | -472.30K | -504.40K | -417.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -225.90K | -63.60K | -472.30K | -504.40K | -417.50K |
| EBIT | -232.20K | -63.20K | -473.30K | -501.70K | -428.90K |
| EBITDA | -226.80K | -57.20K | -466.50K | -494.40K | -403.40K |
| EPS Basic | -0.02 | -0.01 | -0.04 | -0.05 | -0.06 |
| Normalized Basic EPS | -0.01 | 0.00 | -0.03 | -0.03 | -0.04 |
| EPS Diluted | -0.02 | -0.01 | -0.04 | -0.05 | -0.06 |
| Normalized Diluted EPS | -0.01 | 0.00 | -0.03 | -0.03 | -0.04 |
| Average Basic Shares Outstanding | 11.94M | 11.94M | 11.59M | 9.84M | 7.26M |
| Average Diluted Shares Outstanding | 11.94M | 11.94M | 11.59M | 9.84M | 7.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |